DIN 02461781 — REXULTI 3 MG
REXULTI is a tablet of Brexpiprazole marketed by OTSUKA PHARMACEUTICAL CO LTD. The full Brexpiprazole monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02461781
- Brand name
- REXULTI
- Active ingredient
- Brexpiprazole
- Strength
- 3 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- OTSUKA PHARMACEUTICAL CO LTD
- Health Canada status
- MARKETED
- Drug class
- Atypical antipsychotic (serotonin-dopamine activity modulator)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Brexpiprazole products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02461749 | REXULTI | 0.25 MG | TABLET | OTSUKA PHARMACEUTICAL CO LTD | MARKETED |
| 02461757 | REXULTI | 0.5 MG | TABLET | OTSUKA PHARMACEUTICAL CO LTD | MARKETED |
| 02461765 | REXULTI | 1 MG | TABLET | OTSUKA PHARMACEUTICAL CO LTD | MARKETED |
| 02461773 | REXULTI | 2 MG | TABLET | OTSUKA PHARMACEUTICAL CO LTD | MARKETED |
| 02461803 | REXULTI | 4 MG | TABLET | OTSUKA PHARMACEUTICAL CO LTD | MARKETED |